These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
896 related articles for article (PubMed ID: 21138536)
1. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades. Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536 [TBL] [Abstract][Full Text] [Related]
2. Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity. Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P Vaccine; 2018 Aug; 36(33):5097-5103. PubMed ID: 30007825 [TBL] [Abstract][Full Text] [Related]
3. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model. Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951 [TBL] [Abstract][Full Text] [Related]
4. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses. Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193 [TBL] [Abstract][Full Text] [Related]
5. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses. Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
7. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses. Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709 [TBL] [Abstract][Full Text] [Related]
8. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection. Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598 [TBL] [Abstract][Full Text] [Related]
9. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. Houser KV; Pearce MB; Katz JM; Tumpey TM J Virol; 2013 Dec; 87(24):13480-9. PubMed ID: 24089569 [TBL] [Abstract][Full Text] [Related]
10. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes. Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407 [TBL] [Abstract][Full Text] [Related]
11. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. Walz L; Kays SK; Zimmer G; von Messling V J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654 [TBL] [Abstract][Full Text] [Related]
12. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants. Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710 [TBL] [Abstract][Full Text] [Related]
13. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus. Lee GJ; Chu KB; Inn KS; Moon EK; Quan FS Immunol Invest; 2020 Oct; 49(7):781-793. PubMed ID: 31774021 [TBL] [Abstract][Full Text] [Related]
15. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study. McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535 [TBL] [Abstract][Full Text] [Related]
16. Vaccine-induced NA immunity decreases viral shedding, but does not disrupt chains of airborne transmission for the 2009 pandemic H1N1 virus in ferrets. Septer KM; Heinly TA; Sim DG; Patel DR; Roder AE; Wang W; Chung M; Johnson KEE; Ghedin E; Sutton TC mBio; 2024 Oct; 15(10):e0216124. PubMed ID: 39248566 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses. Allen JD; Ross TM Front Immunol; 2021; 12():707339. PubMed ID: 34475872 [TBL] [Abstract][Full Text] [Related]
18. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice. Lei H; Peng X; Jiao H; Zhao D; Ouyang J Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406 [TBL] [Abstract][Full Text] [Related]
19. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745 [TBL] [Abstract][Full Text] [Related]
20. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019. Allen JD; Ross TM J Virol; 2022 Apr; 96(7):e0165221. PubMed ID: 35289635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]